- Home
- Publications
- Publication Search
- Publication Details
Title
Wnt Signaling in Gynecologic Malignancies
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 12, Pages 4272
Publisher
MDPI AG
Online
2020-06-17
DOI
10.3390/ijms21124272
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis
- (2020) Marwa Asem et al. CANCER RESEARCH
- Proteogenomic Characterization of Endometrial Carcinoma
- (2020) Yongchao Dou et al. CELL
- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
- (2020) Youn-Sang Jung et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Antiepileptic Drug Carbamazepine Binds to a Novel Pocket on the Wnt Receptor Frizzled-8
- (2020) Yuguang Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Expression of Wnt pathway molecules is associated with disease outcome in metastatic high-grade serous carcinoma
- (2020) Michal Chehover et al. VIRCHOWS ARCHIV
- Inhibition of Wnt signalling pathway by XAV939 enhances radiosensitivity in human cervical cancer HeLa cells
- (2020) Jinhua Zhang et al. Artificial Cells Nanomedicine and Biotechnology
- Aberrant WNT/CTNNB1 Signaling as a Therapeutic Target in Human Breast Cancer: Weighing the Evidence
- (2020) Emma H. van Schie et al. Frontiers in Cell and Developmental Biology
- Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer
- (2020) Ilaria Betella et al. GYNECOLOGIC ONCOLOGY
- Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment
- (2020) Whitney N. Goldsberry et al. Cancers
- WNT/β-catenin pathway activation correlates with immune exclusion across human cancers
- (2019) Jason J. Luke et al. CLINICAL CANCER RESEARCH
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
- (2019) Lorenzo Castagnoli et al. ONCOGENE
- High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
- (2019) Michael-Antony Lisio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Endometrioid Carcinoma
- (2019) Danielle C. Costigan et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers
- (2019) Marisa R. Moroney et al. GYNECOLOGIC ONCOLOGY
- N6-methylation of adenosine (m6A) of FZD10 mRNA contributes to PARP inhibitor resistance
- (2019) Takeshi Fukumoto et al. CANCER RESEARCH
- Convergence of Wnt and Notch signaling controls ovarian cancer cell survival
- (2019) Sebastián Bocchicchio et al. JOURNAL OF CELLULAR PHYSIOLOGY
- SALL4 promotes the tumorigenicity of cervical cancer cells through activation of Wnt/β‐catenin pathway via CTNNB1
- (2019) Mei Chen et al. CANCER SCIENCE
- The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice
- (2019) Hiroyasu Okazaki et al. EXPERIMENTAL LUNG RESEARCH
- WNT5A gene and protein expression in endometrial cancer
- (2019) Tomasz Wasniewski et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Activation of Wnt signaling promotes olaparib resistant ovarian cancer
- (2019) Tomomi M. Yamamoto et al. MOLECULAR CARCINOGENESIS
- The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models
- (2019) Betty Y. Tam et al. CANCER LETTERS
- A phase 1b dose escalation study of ipafricept (OMP 54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer
- (2019) Kathleen N. Moore et al. GYNECOLOGIC ONCOLOGY
- Toward understanding the origin and evolution of cellular organisms
- (2019) Minoru Kanehisa PROTEIN SCIENCE
- Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt/β-Catenin Signaling in Ovarian Cancer
- (2019) Xiaohong Ruan et al. Molecular Therapy-Oncolytics
- Wnt family member 4 (WNT4) and WNT3A activate cell-autonomous Wnt signaling independent of porcupine O-acyltransferase or Wnt secretion
- (2019) Deviyani M. Rao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
- (2019) Zachary L. Watson et al. Clinical Epigenetics
- Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance
- (2019) Teeuwssen et al. Journal of Clinical Medicine
- Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination—Review of Current Perspectives
- (2019) Chee Kai Chan et al. Journal of Oncology
- Pyrvinium pamoate inhibits proliferation and invasion of human endometriotic stromal cells
- (2019) A Karamian et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- IL‐8 promotes cell migration through regulating EMT by activating the Wnt/β‐catenin pathway in ovarian cancer
- (2019) Jirui Wen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis
- (2019) Vu Hong Loan Nguyen et al. Journal of Ovarian Research
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- Oestrogen fuels the growth of endometrial hyperplastic lesions initiated by overactive Wnt/β-catenin signalling
- (2018) Jyoti Goad et al. CARCINOGENESIS
- Wnt signalling: conquering complexity
- (2018) Katrin E. Wiese et al. DEVELOPMENT
- Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε
- (2018) Balbina García-Reyes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association
- (2018) Grace Kim et al. MODERN PATHOLOGY
- Is β-Catenin a Druggable Target for Cancer Therapy?
- (2018) Can Cui et al. TRENDS IN BIOCHEMICAL SCIENCES
- KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer
- (2018) Yaqin Wu et al. OncoTargets and Therapy
- SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer
- (2018) Lu Li et al. Cell Death & Disease
- DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt/β-catenin pathway via GSK3β
- (2018) Xiao-Fang Liu et al. Cell Death & Disease
- Mechanisms of Wnt signaling and control
- (2018) Stephanie Grainger et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Wnt signaling in cervical cancer?
- (2018) Min Yang et al. Journal of Cancer
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016
- (2018) et al. JAMA Oncology
- A novel porcupine inhibitor blocks WNT pathways and attenuates cardiac hypertrophy
- (2018) Jiahui Jiang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An update of Wnt signalling in endometrial cancer and its potential as a therapeutic target
- (2018) Amy Coopes et al. ENDOCRINE-RELATED CANCER
- A synthetic anti-Frizzled antibody engineered for broadened specificity exhibits enhanced anti-tumor properties
- (2018) Zvezdan Pavlovic et al. mAbs
- Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling
- (2018) Geyan Wu et al. CLINICAL CANCER RESEARCH
- Genomic characterization of cervical cancer based on human papillomavirus status
- (2018) Liya Zhang et al. GYNECOLOGIC ONCOLOGY
- Cancer of the cervix uteri
- (2018) Neerja Bhatla et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- HPV-18 E6 Oncoprotein and Its Spliced Isoform E6*I Regulate the Wnt/β-Catenin Cell Signaling Pathway through the TCF-4 Transcriptional Factor
- (2018) J. Muñoz-Bello et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long noncoding RNA HOTAIR knockdown inhibits autophagy and epithelial-mesenchymal transition through the Wnt signaling pathway in radioresistant human cervical cancer HeLa cells
- (2018) Xinggang Guo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Wnt signaling dynamics in head and neck squamous cell cancer tumor-stroma interactions
- (2018) Phuong N. Le et al. MOLECULAR CARCINOGENESIS
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of R-spondin 1 through activating Wnt/β-catenin in the growth, survival and migration of ovarian cancer cells
- (2018) Qiong Liu et al. GENE
- PARP inhibitors: Clinical utility and possibilities of overcoming resistance
- (2017) Benjamin G. Bitler et al. GYNECOLOGIC ONCOLOGY
- Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/β-Catenin Signaling Pathway
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Robert L Coleman et al. LANCET
- Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
- (2017) Elizabeth M Swisher et al. LANCET ONCOLOGY
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence
- (2017) Katherine C Kurnit et al. MODERN PATHOLOGY
- E6 proteins of α and β cutaneous HPV types differ in their ability to potentiate Wnt signaling
- (2017) Sophia Sominsky et al. VIROLOGY
- Clinical significance and biological role of Wnt10a in ovarian cancer
- (2017) Ping Li et al. Oncology Letters
- DACT1 Overexpression in type I ovarian cancer inhibits malignant expansion and cis-platinum resistance by modulating canonical Wnt signalling and autophagy
- (2017) Ruo-nan Li et al. Scientific Reports
- Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy
- (2017) Chongyuan Zhang et al. MEDICAL SCIENCE MONITOR
- Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial
- (2017) Kiminori Kimura et al. EBioMedicine
- Secreted Frizzled-related protein 4 (sFRP4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines
- (2017) A. Deshmukh et al. Scientific Reports
- Endometrial cancer: Not your grandmother's cancer
- (2016) Jessica N. McAlpine et al. CANCER
- Advances in diagnosis and treatment of metastatic cervical cancer
- (2016) Haoran Li et al. Journal of Gynecologic Oncology
- Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer
- (2016) Tze-Kiong Er et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Blocking c-Met–mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
- (2016) Yi Du et al. NATURE MEDICINE
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling
- (2016) S Bernaudo et al. ONCOGENE
- Wnt-11 overexpression promoting the invasion of cervical cancer cells
- (2016) Heng Wei et al. TUMOR BIOLOGY
- Expression of WNT genes in cervical cancer-derived cells: Implication of WNT7A in cell proliferation and migration
- (2015) Moisés Ramos-Solano et al. EXPERIMENTAL CELL RESEARCH
- Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
- (2015) Ellen Stelloo et al. MODERN PATHOLOGY
- Tankyrase Inhibition Causes Reversible Intestinal Toxicity in Mice with a Therapeutic Index < 1
- (2015) Yu Zhong et al. TOXICOLOGIC PATHOLOGY
- Regulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins
- (2015) Jesus Bello et al. Viruses-Basel
- Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
- (2015) Anil Belur Nagaraj et al. Oncotarget
- Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively
- (2015) Kensaku Shojima et al. Scientific Reports
- Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling
- (2014) Yu Fan et al. FEBS Journal
- β-Catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers
- (2014) Andrea Myers et al. GYNECOLOGIC ONCOLOGY
- Clinical Significance of CTNNB1 Mutation and Wnt Pathway Activation in Endometrioid Endometrial Carcinoma
- (2014) Yuexin Liu et al. JNCI-Journal of the National Cancer Institute
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Clinical significance of Wnt-11 and squamous cell carcinoma antigen expression in cervical cancer
- (2014) Heng Wei et al. MEDICAL ONCOLOGY
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- HPV16 E6 and E6AP differentially cooperate to stimulate or augment Wnt signaling
- (2014) Sophia Sominsky et al. VIROLOGY
- The Wnt/β-catenin pathway in ovarian cancer: A review
- (2013) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- Overexpression of Wnt7a Is Associated With Tumor Progression and Unfavorable Prognosis in Endometrial Cancer
- (2013) Yunduo Liu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway
- (2013) Xiao-Hong Tian et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
- (2012) J. S. Nielsen et al. CLINICAL CANCER RESEARCH
- Use of mutation profiles to refine the classification of endometrial carcinomas
- (2012) Melissa K McConechy et al. JOURNAL OF PATHOLOGY
- Correction: FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features
- (2012) Sara A. Byron et al. PLoS One
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
- (2012) A. Gurney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence
- (2011) B. G. Bitler et al. CANCER RESEARCH
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Beta-Catenin Accelerates Human Papilloma Virus Type-16 Mediated Cervical Carcinogenesis in Transgenic Mice
- (2011) Gülay Bulut et al. PLoS One
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
- (2010) Curtis A Thorne et al. Nature Chemical Biology
- Progesterone Inhibition of Wnt/ -Catenin Signaling in Normal Endometrium and Endometrial Cancer
- (2009) Y. Wang et al. CLINICAL CANCER RESEARCH
- Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling
- (2009) Amanda Mikels et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- β-catenin mediates glandular formation and dysregulation of β-catenin induces hyperplasia formation in the murine uterus
- (2008) J-W Jeong et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now